EnteroMedics Inc. (ETRM):(医療機器分野)企業M&A及び提携動向

◆英語タイトル:EnteroMedics Inc. (ETRM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME12407D
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月16日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

EnteroMedics Inc. (Enteromedics) is a medical device manufacturer. The company designs and develops medical devices for the treatment of obesity and other gastrointestinal disorders. It develops and provides VBLOC therapy which is used in the treatment of gastrointestinal and metabolic diseases. EnteroMedics’ VBLOC therapy is delivered by a pacemaker device called the maestro rechargeable system. The company’s maestro rechargeable system is designed to control hunger and fullness by blocking the primary nerve which regulates the digestive system. Enteromedics is headquartered in St. Paul, Minnesota, the US.

EnteroMedics Inc. (ETRM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
EnteroMedics Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
EnteroMedics Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 6
EnteroMedics Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
EnteroMedics Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 8
EnteroMedics Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 9
EnteroMedics Inc., Medical Equipment, Deal Details 10
Partnerships 10
EnteroMedics Extends Research and Development Agreement With Mayo Clinic 10
Equity Offering 11
EnteroMedics Announces Public Offering Of Common Stock For US$20 Million 11
EnteroMedics Completes Public Offering Of Common Stock And Warrants For US$13 Million 12
EnteroMedics Announces Private Placement Of Shares For US$45 Million 14
EnteroMedics Completes Private Placement Of Shares For US$3.6 Million Upon Exercise Of Warrants 16
EnteroMedics Completes Private Placement Of Shares For US$5 Million 17
EnteroMedics Completes Underwritten Public Offering Of Common Stock For US$14.5 Million 19
EnteroMedics Completes Public Offering Of US$29.8 Million 21
EnteroMedics Completes Private Placement Of Convertible Preferred Stock Common For US$5.85 Million 23
EnteroMedics Completes Private Placement Of US$4.83 Million 25
EnteroMedics Completes Registered Direct Offering Of Common Stock For US$5 Million 27
EnteroMedics Completes Private Placement Of US$15.9 Million 29
Acquisition 31
Mayo Clinic Acquires Equity Stake In EnteroMedics 31
EnteroMedics Inc. – Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Recent Developments 35
Product News 35
Nov 13, 2014: EnteroMedics to Participate at the 2014 Canaccord Genuity Medical Technology and Diagnostics Forum 35
Sep 29, 2014: EnteroMedics’ CE Mark For Maestro RC System Now Includes Type 2 Diabetes Treatment 36
Jun 17, 2014: EnteroMedics Announces FDA Advisory Committee Recommendation on VBLOC Vagal Blocking Therapy for the Treatment of Obesity 37
Mar 10, 2014: EnteroMedics Announces the FDA Has Rescheduled the Advisory Committee Meeting Date to June 17, 2014 for Review of Maestro Rechargeable System 38
Feb 12, 2014: EnteroMedics Announces Food and Drug Administration Advisory Committee Meeting Date for Review of the Maestro Rechargeable System for the Treatment of Obesity 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
EnteroMedics Inc., Medical Equipment, Key Facts, 2013 1
EnteroMedics Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 1
EnteroMedics Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
EnteroMedics Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 6
EnteroMedics Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
EnteroMedics Inc., Deals By Market, 2009 to YTD 2015 8
EnteroMedics Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 9
EnteroMedics Extends Research and Development Agreement With Mayo Clinic 10
EnteroMedics Announces Public Offering Of Common Stock For US$20 Million 11
EnteroMedics Completes Public Offering Of Common Stock And Warrants For US$13 Million 12
EnteroMedics Announces Private Placement Of Shares For US$45 Million 14
EnteroMedics Completes Private Placement Of Shares For US$3.6 Million Upon Exercise Of Warrants 16
EnteroMedics Completes Private Placement Of Shares For US$5 Million 17
EnteroMedics Completes Underwritten Public Offering Of Common Stock For US$14.5 Million 19
EnteroMedics Completes Public Offering Of US$29.8 Million 21
EnteroMedics Completes Private Placement Of Convertible Preferred Stock Common For US$5.85 Million 23
EnteroMedics Completes Private Placement Of US$4.83 Million 25
EnteroMedics Completes Registered Direct Offering Of Common Stock For US$5 Million 27
EnteroMedics Completes Private Placement Of US$15.9 Million 29
Mayo Clinic Acquires Equity Stake In EnteroMedics 31
EnteroMedics Inc., Key Competitors 32
EnteroMedics Inc., Key Employees 33

List of Figures
EnteroMedics Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 1
EnteroMedics Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 1
EnteroMedics Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 1
EnteroMedics Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 1
EnteroMedics Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
EnteroMedics Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 6
EnteroMedics Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
EnteroMedics Inc., Medical Equipment, Deals by Market, 2009 to YTD 2015 8

★調査レポート[EnteroMedics Inc. (ETRM):(医療機器分野)企業M&A及び提携動向] (コード:GDME12407D)販売に関する免責事項を必ずご確認ください。
★調査レポート[EnteroMedics Inc. (ETRM):(医療機器分野)企業M&A及び提携動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆